Navigation Links
GenSpera's CEO Shares Insight on Unique Properties and Targeting of Lead Drug G-202, Based on the Thapsigargin Toxin
Date:8/5/2014

r industry peers is that G-202 is an active drug that does exactly what it is designed to do and at doses that are very well-tolerated by the patients.

Q: Investorideas.com
Can you talk about the multiple cancers that G-202 can potentially treat and the kind of market opportunity each represents?

A: Dr. Craig Dionne, PhD, GenSpera CEO
We expect G-202 to be useful in a wide range of malignant tumor types, which covers a multi-billion dollar industry opportunity for GenSpera. There are approximately 240,000 new cases of prostate cancer diagnosed in the US each year. The market for prostate cancer drugs is expected to reach $6.7 billion by 2020. Hepatocellular carcinoma is the third largest cancer killer worldwide with an expected market size of $1.5 billion by 2019. Glioblastoma is a smaller market but sales of the approved drug Avastin in those patients is expected to reach $460 million by 2017. However we view glioblastoma as a proof of concept for treating brain tumors; if successful, we expect that G-202 could be used to treat lung and breast cancers that metastasize to the brain, which is a 10-fold larger market than glioblastoma alone.

Q: Investorideas.com
How would you describe the G-202 proof of concept to-date in terms that an average reader could understand, outside of the scientific community?

A: Dr. Craig Dionne, PhD, GenSpera CEO
G-202 is designed to be activated only within the blood vessels of tumors and to kill those blood vessels directly, thus starving the tumors to death. We used a very sophisticated imaging technique to demonstrate that G-202 treatment nearly obliterated tumor blood flow in a liver cancer patient after only two cycles of treatment. These results bode well for our prostate cancer and glioblastoma (brain cancer) clinical trials, which use exactly the same dosing regimen.

Q: Investorideas.com
Craig with your recent data on
'/>"/>

SOURCE Investorideas.com
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. ResearchMoz: Oxygen Concentrator Market Shares, Strategies and Forecasts, Worldwide, 2012 to 2018
2. Medisafe 1 Technologies to Start the $1MM Stock Repurchase Program of 10MM Shares up to 10 Cents a Share
3. Rosetta Genomics Announces Closing of Public Offering of 5.5 Million Ordinary Shares
4. My Cleaning Products Compiles Pictures of Bed Bugs, Shares How to Use Them Effectively to Eliminate the Pests
5. Probiotic Action Representative Fernando Perez Shares Tips for Parents with Teens Suffering from Acne and Depression
6. Don't Make That Critical Mistake That Rules Out Candidates From Job Interviews - Career Coach Shares Secrets to Impressive Interviewers
7. ResearchMoz: DSL Chips Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2018 - Market Research Report
8. Unique Bed Bug Extermination Solution Revealed To The Public and Its Complimentary Sample Offered, MyCleaningProducts.com Shares Details Where to Get It
9. BioMed Realty Trust Prices Public Offering Of 12,700,000 Shares Of Common Stock
10. A Rust Remover That Saves Contractors $1,000 Now Offers Complimentary Samples, My Cleaning Products Shares Where to Get One
11. DistinctBright "The Best Probiotic Cleaner Company" Shares Tips for Green Cleaning
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... York, NY (PRWEB) December 16, 2014 ... significant changes since 2013, which is why IBISWorld updated ... this industry continues to benefit from an intensified focus ... the proposal for new emission standards for power plants ... industry operators. According to IBISWorld Industry Analyst Sarah Kahn, ...
(Date:12/17/2014)... Washington, USA (PRWEB) December 16, 2014 ... Baum, manager at Philipps- Universität Marburg’s Department of ... and photonics, in the newly released SPIE ... “And never be too shy to ask questions.” ... (science, technology, engineering, and mathematics) occupations ranging from ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Ipsen ... IPN; ADR: IPSEY), today announced that ... to as Somatuline®) was approved by the U.S. ... of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients ... or metastatic disease to improve progression-free survival (PFS). ...
(Date:12/17/2014)... December 17, 2014 This report ... Quartz Tubing industry. For an overview analysis, the ... application, industry chain structure, industry overview, policy analysis, ... tubing industry has witnessed rapid development with ... of acquisitions. This report mentions quartz tubing upstream ...
Breaking Biology Technology:Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 82020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2
... Company to Provide Business Systems and Technology Support to NIH Office ... ... 5 SRA International, Inc.,(NYSE: SRX ), a leading provider ... has been,awarded a competitive task order to provide a broad range ...
... Oct. 5 The Coalition for a,Competitive Pharmaceutical ... Food and Drug Administration,s announcement regarding its,"Generic Initiative ... employers, insurers, and policymakers grappling with,how to manage ... FDA,and Congress continue to focus on ways to ...
... Lexicon,Pharmaceuticals, Inc. (Nasdaq: LXRX ) today announced ... executive officer, will present,at the BIO InvestorForum at The ... 2007 at 11:00 a.m. Pacific Time. A live ... website at http://www.lexpharma.com . An archived version of ...
Cached Biology Technology:National Institutes of Health Awards $25.5M Contract to SRA 2CCPM Issues Statement on FDA's GIVE Initiative 2Lexicon Pharmaceuticals to Present at Bio InvestorForum 2
(Date:12/19/2014)... Dec. 18, 2014   LaunchKey , the first ... post-password and Internet of Things era, today announced the ... venture round was led by Metamorphic Ventures with participation ... Partners, VegasTechFund, and others.  LaunchKey has raised $4 million ... expand its team and bring LaunchKey to market in ...
(Date:12/17/2014)... YORK , Dec. 15, 2014  HITLAB ... Good Clinical Practices (GCP) audit to confirm its ... (FDA) regulations. This accomplishment enables HITLAB to conduct ... utilizing the highest principles for patient safety and ... improve global healthcare access, quality, and delivery with ...
(Date:12/17/2014)... 16, 2014  Automation is fundamentally transforming the ... than at international borders. Over the past decade, ... allowed veteran travelers to self process through border ... Kiosks at an increasing number of airports, seaports, ... According to Maxine Most , Principal ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
... of vocal mimicry, researchers from the Wildlife Conservation Society (WCS) ... cat species imitating the call of its intended victim: a ... the first recorded instance of a wild cat species in ... extraordinary behavior was recorded by researchers from the Wildlife Conservation ...
... leave the pediatrician,s office if your child has strep ... treatment. A novel application for applying DNA "nanobarcodes" ... and more accurately determine what,s causing a patient,s acute ... R. Hartman, a Cornell University PhD candidate in Biological ...
... Elsevier, a world leader in health care, medical publishing ... Legacy Interactive, announced today the release of Top Doc, ... designed to let medical students, residents and junior faculty ... and Legacy Interactive developed the app,s interactive format to ...
Cached Biology News:Wildlife Conservation Society finds wild cat mimicking monkey calls 2Instant testing for sore throats wins CIMIT prize 2Instant testing for sore throats wins CIMIT prize 3Instant testing for sore throats wins CIMIT prize 4Elsevier and Legacy Interactive partner to launch iPhone app 2
... The RapidCycler is the first instrument ... reactions and is used by thousands of ... Roche LightCycler Capillary tubes which are ideally ... their thin walls and extremely high surface-area-to-volume ...
... of human cullin genes (CUL-1, -2, -3, -4a, -4b, ... Cullin-3 is proposed to be a part of E3 ... E and targets it for ubiquitination, which leads to ... of cdk2, which leads the cell to S phase. ...
Yellow oily liquid. Contains 85% Drakeol 5NF, 15% Arlacel A (mannide monooleate emulsifier). Heat sterilized. Contains zero colony forming units/ml. ...
... LED produces output at 470 nm; includes interface ... S2000 or installed into rack or desktop boxes ... Source is an LED that produces either pulsed ... blue region -- for fluorescence measurements. The source ...
Biology Products: